These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 28481657)
21. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery. Zu Y; Meng L; Zhao X; Ge Y; Yu X; Zhang Y; Deng Y Int J Nanomedicine; 2013; 8():1207-22. PubMed ID: 23569373 [TBL] [Abstract][Full Text] [Related]
22. Preparation and characterization of 10-hydroxycamptothecin loaded nanostructured lipid carriers. Liu K; Sun J; Wang Y; He Y; Gao K; He Z Drug Dev Ind Pharm; 2008 May; 34(5):465-71. PubMed ID: 18473227 [TBL] [Abstract][Full Text] [Related]
23. Preparation and evaluation of poly-butylcyanoacrylate nanoparticles for oral delivery of thymopentin. He W; Jiang X; Zhang ZR J Pharm Sci; 2008 Jun; 97(6):2250-9. PubMed ID: 17853430 [TBL] [Abstract][Full Text] [Related]
24. Sustained release of hydroxycamptothecin after subcutaneous administration using a novel phospholipid complex-DepoFoam technology. Zhao Y; Liu J; Sun X; Zhang ZR; Gong T Drug Dev Ind Pharm; 2010 Jul; 36(7):823-31. PubMed ID: 20515403 [TBL] [Abstract][Full Text] [Related]
25. Colloidal formulations of etoposide based on poly(butyl cyanoacrylate) nanoparticles: preparation, physicochemical properties and cytotoxicity. Yordanov G; Skrobanska R; Evangelatov A Colloids Surf B Biointerfaces; 2013 Jan; 101():215-22. PubMed ID: 23010022 [TBL] [Abstract][Full Text] [Related]
26. Preparation and properties of hydroxycamptothecin-loaded nanoparticles made of amphiphilic copolymer and normal polymer. Wang J; Wang R; Li LB J Colloid Interface Sci; 2009 Aug; 336(2):808-13. PubMed ID: 19520376 [TBL] [Abstract][Full Text] [Related]
27. Development of curcuminoids loaded poly(butyl) cyanoacrylate nanoparticles: Physicochemical characterization and stability study. Mulik R; Mahadik K; Paradkar A Eur J Pharm Sci; 2009 Jun; 37(3-4):395-404. PubMed ID: 19491031 [TBL] [Abstract][Full Text] [Related]
28. Intracellular target delivery of 10-hydroxycamptothecin with solid lipid nanoparticles against multidrug resistance. Liu M; Chen D; Wang C; Chen X; Wen Z; Cao Y; He H J Drug Target; 2015; 23(9):800-5. PubMed ID: 25766079 [TBL] [Abstract][Full Text] [Related]
29. Optimization of paeonol-loaded poly(butyl-2-cyanoacrylate) nanocapsules by central composite design with response surface methodology together with the antibacterial properties. Yao J; Zhang Y; Hu Q; Zeng D; Hua F; Meng W; Wang W; Bao GH Eur J Pharm Sci; 2017 Apr; 101():189-199. PubMed ID: 28189814 [TBL] [Abstract][Full Text] [Related]
30. [Study on liver targeting and sustained release hydroxycamptothecin polybutylcyanoacrylate nanoparticles]. Zhang ZR; Lu W Yao Xue Xue Bao; 1997; 32(3):222-7. PubMed ID: 11327027 [TBL] [Abstract][Full Text] [Related]
31. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application. Wei W; Shi SJ; Liu J; Sun X; Ren K; Zhao D; Zhang XN; Zhang ZR; Gong T J Drug Target; 2010 Aug; 18(7):557-66. PubMed ID: 20131981 [TBL] [Abstract][Full Text] [Related]
32. Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin. Yuan Y; Wen J; Tang J; Kan Q; Ackermann R; Olsen K; Schwendeman A Int J Nanomedicine; 2016; 11():6229-6238. PubMed ID: 27920529 [TBL] [Abstract][Full Text] [Related]
33. [Comparison of bioavailability of two kinds of solid dispersion from 10-hydroxycamptothecin in SD rats in vivo]. Wu XC; Hao HJ; Liu YX; Song XY; Zhang YZ; Zhang HQ Zhongguo Zhong Yao Za Zhi; 2016 Mar; 41(6):1130-1134. PubMed ID: 28875682 [TBL] [Abstract][Full Text] [Related]
34. [Preparation and in vitro drug release study of long-circulating hydroxycamptothecin nanoparticles]. Xi N; Hou LB Zhong Yao Cai; 2010 Apr; 33(4):610-3. PubMed ID: 20845792 [TBL] [Abstract][Full Text] [Related]
35. Enhanced Stability of the Pharmacologically Active Lactone Form of 10-Hydroxycamptothecin by Self-Microemulsifying Drug Delivery Systems. Li R; Wang Y; Yang Q; Lai B; Zhou X; Feng M AAPS PharmSciTech; 2020 Nov; 21(8):324. PubMed ID: 33200259 [TBL] [Abstract][Full Text] [Related]
36. Epirubicin loading in poly(butyl cyanoacrylate) nanoparticles manifests via altered intracellular localization and cellular response in cervical carcinoma (HeLa) cells. Evangelatov A; Skrobanska R; Mladenov N; Petkova M; Yordanov G; Pankov R Drug Deliv; 2016 Sep; 23(7):2235-2244. PubMed ID: 25268149 [TBL] [Abstract][Full Text] [Related]
37. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles. Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683 [TBL] [Abstract][Full Text] [Related]
38. [Pharmaceutical evaluation of hydroxycamptothecin nanosuspensions with the action of inhibiting P-gp]. Pu XH; Sun J; Qin YM; Zhang X; Zhang P; He ZG Yao Xue Xue Bao; 2011 Jul; 46(7):834-8. PubMed ID: 22010354 [TBL] [Abstract][Full Text] [Related]
39. Ftorafur loading and controlled release from poly(ethyl-2-cyanoacrylate) and poly(butylcyanoacrylate) nanospheres. Arias JL; Gallardo V; Ruiz MA; Delgado AV Int J Pharm; 2007 Jun; 337(1-2):282-90. PubMed ID: 17223292 [TBL] [Abstract][Full Text] [Related]
40. Preparation and characterization of polybutylcyanoacrylate magnetic nanoparticles. Ren F; Chen JH; Jiang YD; Chen ZL Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):161-3. PubMed ID: 14965816 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]